Dr. Paul Sax reviews 3 presentations from CROI 2013 looking at new options for treatment-experienced patients with virologic failure.

Dr Paul Sax reviews the widely reported presentation from CROI 2013 on the functional cure of HIV in a baby and looks at the practical and research implications moving forward.

Drs. Eric Topol and J. Craig Venter explain why the true revolution in medicine is just beginning.

Dr. David Johnson stresses the importance of treating patients with hepatitis C and advanced hepatic fibrosis, given that those with sustained treatment response have a lower all-cause mortality rate.

Dr. Paul Sax considers whether data from a recent study evaluating a higher dose of influenza vaccine in patients with HIV are sufficient to affect practice standards.

Can an elected official keep the details of his or her health issues private? The public may be clamoring to know, but do they have that right? A leading bioethicist shares his thoughts.

Dr. Paul Sax looks at 4 top stories from 2012 that are poised to change the way we manage patients with HIV.

Help your patients understand that sexual encounters during travel place them at high risk for sexually transmitted infections, including HIV.

Dr Paul Sax evaluates promising new clinical trial data on a coformulation of emtricitabine/elvitegravir/cobicistat with the tenofovir prodrug TAF.

Doctors give many reasons for providing 'futile' care: 'a miracle could happen'; the patient wants to live to his/her anniversary. If the patient gets a marginal benefit from care, was it futile?